Oncogenic TYK2 P760L kinase is effectively targeted by combinatorial TYK2, mTOR and CDK4/6 kinase blockade.
Woess K, Macho-Maschler S, Van Ingen Schenau DS, Butler M, Lassnig C, Valcanover D, Poelzl A, Meissl K, Maurer B, Brandstoetter T, Vogl C, Koren A, Kubicek S, Orlova A, Moriggl R, Strobl B, Sexl V, Van Leeuwen FN, Kuiper RP, Mueller M.
Woess K, et al. Among authors: koren a.
Haematologica. 2023 Apr 1;108(4):993-1005. doi: 10.3324/haematol.2021.279848.
Haematologica. 2023.
PMID: 35021603
Free PMC article.